Adial Pharmaceuticals, Inc. announced the appointment of Alex Lugovoy as Head of Strategy. Mr. Lugovoy will further develop and advance the Company's corporate partnerships, licensing and mergers and acquisitions strategy. Mr. Lugovoy has almost 20 years of experience working in the pharmaceutical and biotechnology industries. His management consulting and operational experience spans portfolio strategy, licensing, marketing, sales, medical, and research and development. Prior to founding Dobrin Consulting, an addiction-focused consulting firm, Mr. Lugovoy started and led the Business Development, Strategy and M&A department at Reckitt Benckiser Pharmaceuticals (now Indivior), a leading global addiction pharmaceutical company.